Data

Click on Protocol Number of interest to view study-related documentation or download data files. (DTMC data files are under development.)
Division Sort descending Study Number Title Investigator(s) Release Date
CTN NIDA-CTN-0049 Project HOPE - Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users Lisa Metsch, Ph.D., Carlos del Rio, M.D. Sep 07, 2018
CTN NIDA-CTN-0030 A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence Walter Ling, M.D., Roger Weiss, M.D. Jun 22, 2011
CTN NIDA-CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment John Rotrosen, M.D. Jan 12, 2018
CTN NIDA-CTN-0030A3 Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence) Roger Weiss, M.D., Jennifer Sharpe Potter, Ph.D. Aug 22, 2014
CTN NIDA-CTN-0054 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT) Walter Ling, M.D. Oct 09, 2020
CTN NIDA-CTN-0068 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) Madhukar H. Trivedi, M.D. Oct 07, 2022
CTN NIDA-CTN-0031A An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association With Treatment Outcomes in Methamphetamine and Cocaine Abusers T. John Winhusen, Ph.D., Eugene Somoza, M.D. Nov 26, 2013
CTN NIDA-CTN-0075 Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder Li-Tzy Wu, Psy.D., Paolo Mannelli, MD Feb 16, 2023
CTN NIDA-CTN-0093 Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool Gerald Cochran, PhD, T. John Winhusen, Ph.D. Apr 13, 2023
CTN NIDA-CTN-0067 Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up P. Todd Korthuis, MD Jul 26, 2023